VP-315 is a potential first-in-class oncolytic chemotherapeutic peptide immunotherapy administered directly into a tumor to induce immunogenic cell death and thereby unleashing a broad spectrum of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results